ClinicalTrials.gg
Active, not recruitingNCT06091202CORPsUpdated May 28, 2026

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

A Phase 3 interventional study of CORPs Intervention and Minimally Enhanced Usual Care (MEUC) in Chronic Pain, sponsored by Oregon Health and Science University. Active, not recruiting at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-28.

Sponsored by Oregon Health and Science University · Phase 3, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
608
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 1,283 studies in Chronic Pain with a site in United States — 257 open to participants now, 348 under way, 7 of them phase 3. Chronic Pain · United States.

Planned enrollment
45th of 1,092
608 · median 60
Started
2024
with 102 others
Phase 3
65 of 1,283
3 open now
Primary completion
2027-05
later than 176 of 347 live
Registered
1,016th of 1,283
by date

Among the 1,283 studies in Chronic Pain with a site in United States, this one is the 45th largest by planned enrollment of the 1,092 interventional ones that give a count, is one of 103 that started in 2024, is one of 65 in phase 3, reaches primary completion later than 176 of the 347 other live ones, and was the 1,016th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

257 of the 1,283 studies in Chronic Pain with a site in United States are open now. Recruiting first, the newest first:

252 more — sign in →

All 257 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,283 studies in Chronic Pain with a site in United States, or all of them as a file.
02

Study summary

This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care vs. minimally enhanced usual care to improve pain interference over 12 months of follow-up, and (2) oversample women and rural veterans of minoritized race/ethnicity to test heterogeneity of treatment effects across birth sex and race/ethnicity.

Read the detailed description

The CORPs trial is a multisite pragmatic effectiveness trial taking place at four geographically diverse VA sites. The CORPs trial will assess the effectiveness of a nurse-led tele-collaborative pain care intervention (CORPs) compared to a one-time education session with a nurse (minimally enhanced usual care, or MEUC) at improving pain and health outcomes for Veterans living in rural areas. This study focuses on management of pain with non-medication services and therapies.

Veterans who enroll will participate for 12-months and will be randomized to one of 2 groups: 1) CORPs (with access to a nurse by phone/video for the duration of the study), or 2) One-time education session with the nurse by phone/video to review resources for pain. All participants complete research assessments at the start of the study, and at 3-, 6-, 9-, and 12-months by phone.

03

Conditions studied

  • Chronic Pain

Keywords

  • Rural
  • Pain
  • CIH
  • Veteran
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • U.S. Veteran
  • Rural Residence based on Rural Urban Commuting Area codes
  • High Impact Chronic pain, determined through a phone screening
  • Access to landline or cell phone
  • English Speaking

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment that would impact participation in the study
  • Plans to move in the next 3 months
  • Surgery in the past 3 months
  • In long-term inpatient or hospice care
  • Terminal illness (defined as of less than 12 months)
  • Active participation in another pain intervention study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
608 participants (estimated)

Study arms

  • Active comparator
    CORPs Intervention

    The CORPs Intervention is a nurse-led intervention. A) An intake assessment with a Nurse Care Manager at the start of the study by phone or video to discuss the patient's pain experience, care options, and goals. Resources are provided and focus on non-medication options at the VA, and as appropriate, in the community. B) 5 Check-in phone/video appointments with a Nurse Care Manager, scheduled to take place near 2-, 4-, 8-, 12-, and 16-weeks. These visits will provide further assistance with goal planning and care coordination for pain management. C) Optional 6-week virtual group education class covering topics like complementary and integrative approaches to pain, sleep and pain, and the neurobiology of pain. D) Patients in this arm can contact their nurse with questions for the full 12 months of participation.

    Behavioral: CORPs Intervention

  • Placebo comparator
    Minimally Enhanced Usual Care (MEUC)

    The minimally enhanced usual care arm is a one-time education session. A) One-time education session with a Nurse Care Manager by phone/video to review pain resources. These resources focus on non-medication options at the VA, and as appropriate, in the community.

    Behavioral: Minimally Enhanced Usual Care (MEUC)

Interventions

  • BehavioralCORPs Intervention

    Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.

    Also known as: Nurse-led collaborative care

  • BehavioralMinimally Enhanced Usual Care (MEUC)

    Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.

    Also known as: One-time Education Session

06

What researchers measure

Primary outcomes

  1. Pain Interference - Brief Pain Inventory (BPI)

    Pain Interference subscale from the Brief Pain Inventory. Scores are reported on a range of 0 - 10, with higher scores indicating more impairment due to pain.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

Secondary outcomes

  1. Pain Intensity - Brief Pain Inventory (BPI)

    Scores are on a range of 0 - 10, with higher scores indicating more severe pain.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

  2. Physical Functioning - PROMIS Physical Functioning Scale

    Physical Functioning will be assessed with the 4-item PROMIS Physical Functioning scale. The physical function form asks the participant to rate a series of physical function related questions on a scale of 1-5 with one representing a better outcome.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

  3. Quality of Life - Veterans RAND-12 (VR-12)

    Quality of Life will be assessed with the Veterans RAND 12-item Health Survey (VR-12). VR-12 scores are summarized into two scores, a Physical Health component score and a Mental Health component score. Each component score is on a range of 0 - 100, with higher scores indicating more impairment in physical or mental health, respectively.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

  4. Depressive Symptoms - Patient Health Questionnaire-9 (PHQ-9)

    Depressive symptoms will be assessed with the Patient Health Questionnaire-9 (PHQ-9). Scores on the PHQ-9 range from 0 - 24, with higher scores indicating more severe symptoms of depression.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

  5. Anxiety Symptoms - Generalized Anxiety Disorder-7 (GAD-7)

    Anxiety symptoms will be assessed with the Generalized Anxiety Disorder-7 (GAD-7) questionnaire. Scores on the PHQ-9 range from 0 - 24, with higher scores indicating more severe symptoms of depression. Scores on the GAD-7 range from 0 - 21, with higher scores indicating more severe symptoms of anxiety.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

  6. Suicidal Behavior - Electronic Health Record (EHR)

    Data on suicidal behaviors will be extracted from the electronic health record.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

  7. Quality of Sleep - PROMIS Sleep Disturbance Scale

    Quality of sleep will be assessed with the PROMIS Sleep Disturbance 4-item short-form. The sleep disturbance form asks the participant to rate a series of sleep related questions on a scale of 1-5 with one representing a better outcome.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

  8. Engagement in Non-Pharmacological Services/Treatments - Nonpharmacological Self-Care Approaches survey (NSCAP)

    Engagement in nonpharmacological pain treatment will be assess with the Use of Nonpharmacological Self-Care Approaches survey (NSCAP). This survey assesses the number of times each of 9 treatments were used in the past 3 months.

    Time frame: Baseline, 3-, 6-, 9-, and 12 Months

07

Study locations

4 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for May 2027, 33 months after the start.

Of 49 phase 3 interventional studies under Chronic Pain, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 56. This study's planned 33 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2023
First posted
Oct 19, 2023
StartActual
Jul 11, 2024
Primary completionEst.
May 1, 2027
CompletionEst.
Jun 1, 2027
Last update
May 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06091202
Collaborators
National Center for Complementary and Integrative Health (NCCIH), Portland VA Medical Center, Minneapolis Veterans Affairs Medical Center, North Texas Veterans Healthcare System, VA Tennessee Valley Health Care System
Responsible party
Travis Lovejoy (Principal Investigator, Oregon Health and Science University) — Principal investigator
First posted
Oct 19, 2023
Start date
Jul 11, 2024
Primary completion
May 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
May 28, 2026

Study contacts

Travis Lovejoy, PhD, MPH
principal investigator · Oregon Health & Science University, VA Portland Health Care System
Benjamin Morasco, PhD
principal investigator · Oregon Health & Science University, VA Portland Health Care System

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion